Evidence map›Paper›PMID 33950864›Full record

Observational studyEuropean journal of endocrinology2021

Serum sodium alterations in SARS CoV-2 (COVID-19) infection: impact on patient outcome.

Andrea Berni, Danilo Malandrino, Giovanni Corona, Mario Maggi, Gabriele Parenti, Benedetta Fibbi, Loredana Poggesi, Alessandro Bartoloni, Federico Lavorini, Andrea Fanelli and 7 more

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in European journal of endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 3 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 3 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Article
  5. Article
  6. Article
  7. Review
  8. Implications of Dysnatremia and Endocrine Disturbances in COVID-19 Patients.International journal of molecular sciences · 2024
    Review
  9. Article
  10. Observational
  11. Article
  12. Pituitary and SARS CoV-2: An unremitting conundrum.Best practice & research. Clinical endocrinology & metabolism · 2023
    Review
  13. Observational
  14. Review
  15. Article
  16. Observational
  17. Article
  18. [Dysnatremias and their association with morbidity and mortality in patients with COVID- 19].Revista medica del Instituto Mexicano del Seguro Social · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Andrea BerniInternal Medicine Unit 3, Careggi University Hospital, Florence, Italy.
Danilo MalandrinoDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Giovanni CoronaEndocrinology Unit, Medical Department, Azienda Usl Bologna Maggiore-Bellaria Hospital, Bologna, Italy.
Mario MaggiEndocrinology Unit, Careggi University Hospital, Florence, Italy.
Gabriele ParentiEndocrinology Unit, Careggi University Hospital, Florence, Italy.
Benedetta FibbiEndocrinology Unit, Careggi University Hospital, Florence, Italy.
Loredana PoggesiInternal Medicine Unit 3, Careggi University Hospital, Florence, Italy.
Alessandro BartoloniDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Federico LavoriniDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Andrea FanelliInternal Medicine Unit 2, Careggi University Hospital, Florence, Italy.
Giulia ScoccheraInternal Medicine Unit 2, Careggi University Hospital, Florence, Italy.
Carlo NozzoliInternal Medicine Unit 1, Careggi University Hospital, Florence, Italy.
Adriano PerisIntensive Care Unit and Regional ECMO Referral Center, Careggi University Hospital, Florence, Italy.
Filippo PieralliHigh Intensity Internal Medicine Unit, Careggi University Hospital, Florence, Italy.
Riccardo PiniDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Andrea UngarDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Alessandro PeriEndocrinology Unit, Careggi University Hospital, Florence, Italy.
Azienda Ospedaliero-Universitaria Careggi · ITUniversity of Florence · ITAzienda USL di Bologna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveHyponatremia is the most common electrolyte disorder in hospitalized patients and occurs in about 30% of patients with pneumonia. Hyponatremia has been associated with a worse outcome in several pathologic conditions The main objective of this study was to determine whether serum sodium alterations may be independent predictors of the outcome of hospitalized COVID-19 patients. DESIGN AND

methodsIn this observational study, data from 441 laboratory-confirmed COVID-19 patients admitted to a University Hospital were collected. After excluding 61 patients (no serum sodium at admission available, saline solution infusion before sodium assessment, transfer from another hospital), data from 380 patients were analyzed.

results274 (72.1%) patients had normonatremia at admission, 87 (22.9%) patients had hyponatremia and 19 (5%) patients had hypernatremia. We found an inverse correlation between serum sodium and IL-6, whereas a direct correlation between serum sodium and PaO2/FiO2 ratio was observed. Patients with hyponatremia had a higher prevalence of non-invasive ventilation and ICU transfer than those with normonatremia or hypernatremia. Hyponatremia was an independent predictor of in-hospital mortality (2.7-fold increase vs normonatremia) and each mEq/L of serum sodium reduction was associated with a 14.4% increased risk of death.

conclusionsThese results suggest that serum sodium at admission may be considered as an early prognostic marker of disease severity in hospitalized COVID-19 patients.

Indexed as

SARS-CoV-2Severity of Illness IndexAgedAged, 80 and overComorbidityCOVID-19Critical CareFemaleFluorocarbonsHospitalizationHospital MortalityHumansHydrocarbons, BrominatedHypernatremiaHyponatremiaInterleukin-6FluorocarbonsHydrocarbons, BrominatedInterleukin-6perflubronSodium

Identifiers

PMID33950864
PMCPMC9494309
OpenAlexW3158663081

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.